Welcome to the geko website

geko™ device

 

About Firstkind

Firstkind Ltd is a subsidiary of Sky Medical technology Ltd.
We are a UK based science-led medical devices company.

Through our innovative mechanism of non-invasive neuromuscular electrostimulation we have developed a ground-breaking NMES technology platform, OnPulse™, embedded in our industry-leading brand, the geko™ device.

Our range of non-invasive geko™ products are wearable therapy devices tailored to different medical applications, selling both direct and through partnerships and distributors in each clinical area. Clinical areas of interest include the prevention of venous thromboembolism (VTE), the prevention and reduction of oedema and wound healing.

Partnership makes us who we are. We are committed to partnering with healthcare professionals to solve challenging medical problems. Through local partnerships we work with clinicians to overcome challenges that are recognised worldwide. Together we identify clinical needs and translate these into cutting-edge products and evidence-based therapies to simplify treatments for clinicians and improve patient outcomes.

Vision

Our vision is to drive innovation through collaborative partnerships to solve challenging medical problems. To create an innovation-driven, patient-focused company capable of achieving sustainable top-tier performance through outstanding execution and a consistent stream of evidence-based therapies that provide compelling patient benefits, differentiated clinical performance and economic value.

OnPulse Technology

The revolutionary neuromuscular electrostimulation technology developed by Firstkind

Find out more

geko™ product

Hospital Applications Device

Find out more

Partner with us

What can the geko™ do for my patients?

News

Sky and Royal Stoke University Hospital win award for use of ground breaking blood clot prevention technology

News

FDA clears geko™ device for use in non-surgical patients at risk for deep vein thrombosis based on new data demonstrating a zero percent DVT rate in patients after a stroke

News

Innovative geko™ Technology Recognised With Nomination at National Awards